End-of-day quote
Shanghai S.E.
23:00:00 01/07/2024 BST
5-day change
1st Jan Change
4.93
CNY
-1.60%
-1.40%
-9.28%
Jointown Pharmaceutical Group Co., Ltd. Provides Earnings Guidance for the First Half of 2020
Jointown Pharmaceutical Group Co., Ltd. provided earnings guidance for the first half of 2020. The Company predicts the net profit belonging to shareholders of the listed company will be between RMB 1,193 million and RMB 1,226.9 million, with an increase of between RMB 449,824,600 and RMB 483,724,600 compared with the same period of the year before and with a year-on-year increase of between 60.53% and 65.09%.
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 300 million worth of its shares.
06-17
CI
Jointown Pharmaceutical Group Co., Ltd authorizes a Buyback Plan.
06-16
CI
Jointown Pharma's Q1 Profit, Revenue Fall 4%
04-29
MT
Jointown Pharmaceutical Group's 2023 Profit Jumps 4%
04-29
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
04-26
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
04-26
CI
Jointown Pharmaceutical Sets Up Joint AI Lab with Peking University's Wuhan Campus
04-08
MT
Jiuzhoutong Pharmaceutical Investment Co., Ltd. announced that it expects to receive CNY 10.9100689 billion in funding from Jointown Pharmaceutical Group Co., Ltd
26/10/23
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023
26/10/23
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2023
24/08/23
CI
Jointown Pharma's Unit Gets Nod for Registration of Acarbose Tablets
05/07/23
MT
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
24/04/23
CI
Nanjing IASO Biotherapeutics announced that it has received funding from Shanghai Chuanghehui Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
12/01/23
CI
Fujian Fukang Pharmaceutical Co., Ltd. announced that it has received funding from Shaoxing Shangyu Hangzhou Bay Economic Development Zone Holding Group Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
03/01/23
CI
Jointown Pharmaceutical Group Co., Ltd announces decision of Regulatory Authority on the transaction
12/12/22
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
26/10/22
CI
Jointown Pharmaceutical Group Co., Ltd's Equity Buyback announced on April 26, 2022, has expired with 36,138,098 shares, representing 1.94% for CNY 425.67 million.
24/10/22
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Nine Months Ended September 30, 2022
24/10/22
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
10/10/22
CI
Jointown Pharmaceutical Group Co., Ltd announced that it expects to receive CNY 2.33 billion in funding
24/08/22
CI
Jointown Pharmaceutical Group Co., Ltd Reports Earnings Results for the Half Year Ended June 30, 2022
22/08/22
CI
Nanjing Puguang Biotechnology Co., Ltd announced that it has received $15 million in funding from Huatai Zijin Investment Co. Ltd, Nanjing XinGong Investment Group Co., Ltd, Shanghai Wenzhou Investment Management Co., Ltd., Jointown Pharmaceutical Group Co., Ltd
10/07/22
CI
Tranche Update on Jointown Pharmaceutical Group Co., Ltd's Equity Buyback Plan announced on April 26, 2022.
01/07/22
CI
Amcare Lab announced that it has received $31 million in funding from Jointown Pharmaceutical Group Co., Ltd, Technology Financial Group, Fosun Group, K2VC, Bison Capital Asset Management, LLC, CICC Capital Management Co., Ltd.
08/06/22
CI
Jointown Pharmaceutical Group Co., Ltd announces an Equity Buyback for CNY 600 million worth of its shares.
26/04/22
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
Jointown Pharmaceutical Group Co., Ltd. is principally engaged in the wholesaling and retailing of pharmaceuticals and medical equipments. The Company is also engaged in the research, development and production of drugs, as well as the provision of relevant value-added services. The Companyâs products mainly include western medicines, proprietary Chinese medicines, Chinese medicine pieces, Chinese herbal medicines, medical equipments, health care products, cosmetics, among others. The Company mainly provides services to direct sales or franchise stores through its retailing businesses.
More about the company
Last Close Price
4.93
CNY
Average target price
7.856
CNY
Spread / Average Target
+59.35%
Consensus
1st Jan change
Capi.
-9.28% 3.39B +26.32% 76.05B -4.23% 23.81B +15.24% 8.8B +1.71% 8.29B -33.21% 6.77B +19.66% 5.36B +0.89% 4.06B -8.73% 3.77B +8.56% 3.28B
Pharmaceuticals Wholesale
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1